Table 1

Laboratory data on admission

Haematology
 WBC9900/μl
  Neu74%
  Eo3%
  Ba1%
  Mo6%
  Ly16%
 RBC328×104/μl
 Hb9.8 g/dl
 Hct29.4%
 MCV89.6 fl
 MCH29.9 pg
 MCHC33.3%
 Plt35.0×104/μl
Biochemistry
 TP7.1 g/dl
 Alb3.4 g/dl
 BUN25 mg/dl
 Cr1.07 mg/dl
 Na134 mEq/l
 K3.4 mEq/l
 Cl101 mEq/l
 Ca8.9 mg/dl
 LDH204 U/l
 AST15 U/l
 ALT11 U/l
 ALP264 U/l
 T-Bil0.3 mg/dl
 CK73 IU/l
Serology
 CRP0.97 mg/dl
 IgG1724 mg/dl
 IgA641 mg/dl
 IgM99 mg/dl
 ACE13.2 IU/l
 Lysozyme13.2 μg/ml
 KL-6710 U/ml
 RF81 IU/ml
 MPO-ANCA<10 EU
 PR3-ANCA<10 EU
 ESR69 mm/h
Tumour markers
 CEA2.9 ng/ml
 CA19-915.6 IU/ml
 sIL-2R1930 U/ml
PPD skin test (−)
Viral infection
HIV-Ab (−)
HTLV-1-Ab (+)×262144 (serum)×32 (CSF)
HTLV-1 provirus (CSF)4.5×104 copy/ml (free) 1.4×103 copy/ml (intracellular)
BALF
Total cell count 35.7×104/ml
 Mo94.5%
 Neu1.0%
 Ly4.5%
 Eo0.0%
CD4:CD8 ratio 1.4
  • ACE, angiotensin-converting enzyme; Alb, albumin; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; Ba, basophils; BALF, bronchoalveolar lavage fluid; BUN, blood urea nitrogen; CEA, carcinoembryonic antigen; CK, creatine kinase; Cr, creatinine; CRP, C reactive protein; CSF, cerebrospinal fluid; Eo, eosinophils; ESR, erythrocyte sedimentation rate; Hb, haemoglobin; Hct, haematocrit; HTLV-1-Ab, human T-lymphotropic virus type 1 antibody; LDH, lactate dehydrogenase; Ly, lymphocytes; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume; Mo, monocytes; MPO-ANCA, myeloperoxidase antineutrophil cytoplasmic antibodies; Neu, neutrophils; Plt, platelet count; PPD, purified protein derivative; RBC, red blood cell; RF, rheumatoid factor; T-Bil, total bilirubin; TP, total protein; WBC, white blood cell.